comparemela.com

Latest Breaking News On - Innovation pharmaceuticals inc - Page 1 : comparemela.com

MRSA Drugs Global Strategic Research Report 2024: Market to

MRSA Drugs Global Strategic Research Report 2024: Market to
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Dublin
Ireland
Canada
Japan
China
Germany
Absynth-biologics
Baxter-international-inc
Medicines-company
Theravance-biopharma-inc
Paratek-pharmaceuticals-inc
Cempra-inc

Short Interest in Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) Drops By 7.2%

Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX – Get Free Report) was the target of a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 466,200 shares, a decrease of 7.2% from the September 30th total of 502,600 shares. Based on an average trading volume of 1,622,400 shares, […]

Innovation-pharmaceuticals
News-ratings-for-innovation-pharmaceuticals-daily
Innovation-pharmaceuticals-stock-performance
Innovation-pharmaceuticals-inc
Get-free-report
Pharmaceuticals-inc
Innovation-pharmaceuticals-daily
Otcmkts-ipix
Ipix
Medical
Stocks

Global MRSA Drugs Markets, 2017-2022, 2022-2027F, 2032F: Focus on Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, & Lipoglycopeptide

/PRNewswire/ The "Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com s.

South-korea
United-kingdom
India
Brazil
Denmark
Australia
Ukraine
Japan
Russia
Indonesia
Germany
China

Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024

WAKEFIELD, MA, Aug. 28, 2023 (GLOBE NEWSWIRE) via NewMediaWire Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company and minority stakeholder in BT BeaMed Technologies (“BeaMed”), is pleased to provide shareholders with an update on recent progress in the development of BeaMed’s groundbreaking StingRay Laser System (the “System”). BeaMed is a pioneering company dedicated to revolutionizing epilepsy and cancer surgery through laser-based innovat

Israel
United-states
Gil-shapira
Moshe-eshkol
Leo-ehrlich
Israel-institute-of-technology
Exchange-commission
Innovation-pharmaceuticals-inc
Rambam-health-care-campus
Massachusetts-institute-of-technology
Newmediawire-innovation-pharmaceuticals
Innovation-pharmaceuticals

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

A study conducted at the University of São Paulo (USP) in Brazil shows that brilacidin, a new drug tested for treatment of diseases ranging from bacterial skin infections to COVID-19, can kill drug-resistant strains of fungi when combined with two classes of antifungals available on the market.

United-states
Pakistan
Brazil
India
Brazilian
Gustavo-henrique-goldman
Megan-craig
Nature-communications
Innovation-pharmaceuticals-inc
World-health-organization
Preto-school-of-pharmaceutical-sciences
Preto-school

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.